Symphony Financial’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$857K Buy
3,624
+214
+6% +$44.5K 0.09% 141
2026
Q1
$712K Buy
3,410
+70
+2% +$15.1K 0.09% 136
2025
Q4
$691K Sell
3,340
-5,242
-61% -$986K 0.09% 132
2025
Q3
$1.34M Buy
+8,582
New +$1.33M 0.16% 103
2024
Q3
Sell
-6,900
Closed -$674K 229
2024
Q2
$674K Buy
+6,900
New +$703K 0.12% 118
2024
Q1
Sell
-5,836
Closed -$596K 195
2023
Q4
$596K Buy
+5,836
New +$579K 0.13% 122

Other funds holding CAH

Symphony Financial's CAH Position: Q2 2026 in Review

Symphony Financial increased its Cardinal Health (CAH) stake by 6.3% in Q2 2026, buying an estimated $44.5K and bringing the position to 3,624 shares worth $857K. The position accounts for 0.09% of the portfolio, ranked #141.

Symphony Financial first reported a position in CAH in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.34M in Q3 2025. 1,239 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Symphony Financial held 3,624 shares of Cardinal Health worth $857K as of Q2 2026.
  • Symphony Financial bought 214 Cardinal Health shares in Q2 2026, an estimated $44.5K.
  • Cardinal Health made up 0.09% of Symphony Financial's portfolio in Q2 2026, its #141 holding.
  • Symphony Financial first reported a position in Cardinal Health in Q4 2023 and has held it in 6 quarters since.
  • Symphony Financial's Cardinal Health position peaked at $1.34M in Q3 2025.
  • 1,239 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Symphony Financial's 13F filing for Q2 2026, filed 4 Aug 2026.